Edwards Lifesciences Corporation Business Combination, Contingent Consideration, Liability, Noncurrent
Edwards Lifesciences Corporation (EW) had Business Combination, Contingent Consideration, Liability, Noncurrent of $14.50 million as of 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent · last filed 2025-02-28
- 2024-12-31: Business Combination, Contingent Consideration, Liability, Noncurrent $14.50M.
- 2023-12-31: Business Combination, Contingent Consideration, Liability, Noncurrent $0.00.
- 2023-09-30: Business Combination, Contingent Consideration, Liability, Noncurrent $0.00.
- 2023-06-30: Business Combination, Contingent Consideration, Liability, Noncurrent $0.00.
| Period end | Business Combination, Contingent Consideration, Liability, Noncurrent |
|---|---|
| 2024-12-31 | $14.50M 10-K · filed 2025-02-28 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-28 |
| 2023-09-30 | $0.00 10-Q · filed 2023-10-27 |
| 2023-06-30 | $0.00 10-Q · filed 2023-07-28 |
| 2023-03-31 | $26.90M 10-Q · filed 2023-04-28 |
| 2022-12-31 | $26.20M 10-K · filed 2024-02-12 |
| 2022-09-30 | $25.70M 10-Q · filed 2022-10-28 |
| 2022-06-30 | $38.20M 10-Q · filed 2022-07-29 |
| 2022-03-31 | $59.10M 10-Q · filed 2022-04-28 |
| 2021-12-31 | $62.00M 10-K · filed 2023-02-13 |
| 2021-09-30 | $80.10M 10-Q · filed 2021-10-29 |
| 2021-06-30 | $79.00M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $181.60M 10-Q · filed 2021-04-28 |
| 2020-12-31 | $186.10M 10-K · filed 2022-02-14 |
| 2020-09-30 | $180.90M 10-Q · filed 2020-10-26 |
| 2020-06-30 | $189.90M 10-Q · filed 2020-07-27 |
| 2020-03-31 | $170.30M 10-Q · filed 2020-04-28 |
| 2019-12-31 | $172.50M 10-K · filed 2021-02-12 |
| 2019-09-30 | $191.00M 10-Q · filed 2019-10-25 |
| 2019-06-30 | $193.30M 10-Q · filed 2019-07-26 |
| 2019-03-31 | $185.30M 10-Q · filed 2019-04-26 |
| 2018-12-31 | $178.60M 10-K · filed 2020-02-14 |
| 2018-09-30 | $192.60M 10-Q · filed 2018-10-26 |
| 2018-06-30 | $199.00M 10-Q · filed 2018-07-27 |
| 2018-03-31 | $196.30M 10-Q · filed 2018-04-27 |
| 2017-12-31 | $192.60M 10-K · filed 2019-02-15 |
| 2017-09-30 | $140.50M 10-Q · filed 2017-10-27 |
| 2017-06-30 | $198.70M 10-Q · filed 2017-07-28 |
| 2017-03-31 | $195.60M 10-Q · filed 2017-04-28 |
| 2016-12-31 | $31.60M 10-K · filed 2018-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |